TABLE 2.
Proportion of patients receiving each tuberculosis drug (n = 213)
| Drug | Received before starting salvage therapy | Received as a part of salvage therapy |
|---|---|---|
|
| ||
| Moxifloxacin | 9.4% (20) | 50.7% (108) |
| Capreomycin | 51.2% (109) | 33.8% (72) |
| Amoxicillin-clavulanate | 56.3% (120) | 23.4% (50) |
| Kanamycin | 53.5% (114) | 20.7% (44) |
| Clarithromycin | 5.6% (12) | 20.7% (44) |
| PAS | 89.7% (191) | 9.4% (20) |
| Streptomycin | 15.0% (32) | 9.4% (20) |
| Pyrazinamide | 43.2% (92) | 8.9% (19) |
| Ethambutol | 32.9% (70) | 7.5% (16) |
| Clofazamine | 51.6% (110) | 6.6% (14) |
| Rifabutin | 1.9% (4) | 5.6% (12) |
| Ethionamide/prothionamide | 83.6% (178) | 4.7% (10) |
| Isoniazid | 5.2% (11) | 3.8% (8) |
| Cycloserine | 96.2% (205) | 2.8% (6) |
| Ciprofloxacin/ofloxacin | 90.6% (193) | 2.8% (6) |
| Rifampicin | 5.2% (11) | 2.8% (6) |
| Levofloxacin | 4.2% (9) | 0.5% (1) |
PAS, para-aminosalicylic acid.